1. Efficacy of Dan’e Fukang Soft Extract in Moderate Ovarian Hyperstimulation Syndrome for Concurrent Treatment of Blood and Fluid Guided by the “Triple Prevention” Principle
- Author
-
Chen,Yan-Hua, Zhang,Xue-Luo, Li,Zhong-Yun, Wang,Xian-Ping, Wang,Jun, Zhang,Zhi-Ping, Zhu,Peng-Fei, Wu,Xue-Qing, Chen,Yan-Hua, Zhang,Xue-Luo, Li,Zhong-Yun, Wang,Xian-Ping, Wang,Jun, Zhang,Zhi-Ping, Zhu,Peng-Fei, and Wu,Xue-Qing
- Abstract
Yan-Hua Chen,1 Xue-Luo Zhang,1 Zhong-Yun Li,2 Xian-Ping Wang,1 Jun Wang,3 Zhi-Ping Zhang,1 Peng-Fei Zhu,1 Xue-Qing Wu1 1Reproductive Medicine Center, Shanxi Maternal and Child Health Care Hospital, Taiyuan, Peopleâs Republic of China; 2Rectum Branch, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, Peopleâs Republic of China; 3The Sixth Hospital of Shanxi Medical University (General Hospital of Tisco), Taiyuan, Peopleâs Republic of ChinaCorrespondence: Xue-Qing Wu, Reproductive Medicine Center, Shanxi Maternal and Child Health Care Hospital, No. 13, Xinmin Middle Street, Xinghualing District, Taiyuan, Shanxi Province, 030013, Peopleâs Republic of China, Tel +86 351-3360725, Email xueqingwu18@outlook.comObjective: This study aimed to evaluate the therapeutic efficacy and safety of Danâe Fukang soft extracts in moderate ovarian hyperstimulation syndrome (OHSS) for the simultaneous treatment of blood and fluid, guided by the traditional Chinese medicine principle of âtriple preventionâ.Methods: This study conducted a retrospective analysis of clinical data from outpatients who underwent in vitro fertilization (IVF)/intracytoplasmic sperm injection embryo transfer (ICSI-ET). A total of 2245 cases were included and divided into a treatment group (1002 cases) and a control group (1243 cases). Patients in the treatment group were administered Danâe Fukang soft extracts orally in addition to conventional Western medicine. Comparative assessments were made between the two groups on pelvic ascites volume, maximum ovary diameter, dysmenorrhea incidence post-oocyte retrieval, and safety indicators.Results: There were no statistically significant differences between the treatment group and the control group in terms of general characteristics or the levels of follicle-stimulating hormone (FSH), luteotropic hormone (LH), estradiol (E2), or progesterone (P) at the time of gonadotropin (Gn) initiation. The groups did not differ significantly when
- Published
- 2024